Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „linagliptin“
Suchtreffer
Begriffe & Kennungen
Glyxambi · 4.5 · Co-administration of a single 5 mg oral dose of linagliptin and multiple 200 mg oral doses of ritonavir, a pot
Eintrag öffnenGlyxambi · 4.5 · Co-administration of rifampicin decreased linagliptin exposure by 40%, suggesting that the efficacy of linagli
Eintrag öffnenGlyxambi · 4.5 · Effects of linagliptin on other medicinal products
Eintrag öffnenGlyxambi · 4.5 · Effects of other medicinal products on linagliptin
Eintrag öffnenGlyxambi · 4.5 · Interaction studies conducted in healthy volunteers suggest that the pharmacokinetics of linagliptin were not
Eintrag öffnenGlyxambi · 4.5 · Linagliptin had no clinically relevant effect on the pharmacokinetics of metformin, glibenclamide, simvastatin
Eintrag öffnenGlyxambi · 4.5 · Linagliptin is a weak competitive and a weak to moderate mechanism-based inhibitor of CYP isozyme CYP3A4, but
Eintrag öffnenGlyxambi · 4.8 · Based on the experience with empagliflozin and linagliptin, an increase of the risk of hypoglycaemia is expect
Eintrag öffnenGlyxambi · 4.8 · Hypoglycaemia with linagliptin The most frequently reported adverse event in clinical trials with linagliptin
Eintrag öffnenJentadueto · 4.5 · 6 respectively, and about 30% decreased DPP-4 inhibition at trough. Thus full efficacy of linagliptin in combi
Eintrag öffnenJentadueto · 4.5 · Digoxin: Co-administration of multiple daily doses of 5 mg linagliptin with multiple doses of 0.25 mg digoxin
Eintrag öffnenJentadueto · 4.5 · Effects of linagliptin on other medicinal products In clinical studies, as described below, linagliptin had no
Eintrag öffnenJentadueto · 4.5 · In vivo assessment of interactions Effects of other medicinal products on linagliptin Clinical data described
Eintrag öffnenJentadueto · 4.5 · Linagliptin In vitro assessment of interactions Linagliptin is a weak competitive and a weak to moderate mecha
Eintrag öffnenJentadueto · 4.5 · Linagliptin is a P-glycoprotein substrate, and inhibits P-glycoprotein mediated transport of digoxin with low
Eintrag öffnenJentadueto · 4.5 · Metformin: Co-administration of multiple daily doses of 10 mg linagliptin with 850 mg metformin hydrochloride,
Eintrag öffnenJentadueto · 4.5 · Oral contraceptives: Co-administration with 5 mg linagliptin did not alter the steady-state pharmacokinetics o
Eintrag öffnenJentadueto · 4.5 · Rifampicin: Multiple co-administration of 5 mg linagliptin with rifampicin, a potent inductor of P-glycoprotei
Eintrag öffnenJentadueto · 4.5 · Ritonavir: Co-administration of a single 5 mg oral dose of linagliptin and multiple 200 mg oral doses of riton
Eintrag öffnenJentadueto · 4.5 · Simvastatin: Multiple daily doses of linagliptin had a minimal effect on the steady-state pharmacokinetics of
Eintrag öffnen